latest news releases from the newsroom
Powerwave Technologies Introduces Clean Site Antenna Systems
CANNES, France, and SANTA ANA, Calif., Feb. 16, 2005 (PRIMEZONE) -- Hall 2, Stand D48 -- Powerwave Technologies, Inc. (Nasdaq:PWAV), a leading supplier of end-to-end wireless infrastructure solutions, will display its Clean Site(TM) antenna systems today at 3GSM World Congress, the mobile industry's premier event, taking place in Cannes, France Feb. 14-17.
UTi Worldwide Announces Management Contract Between Its Standard Corporation and Wal-Mart
RANCHO DOMINGUEZ, Calif., Feb. 16, 2005 (PRIMEZONE) -- UTi Worldwide Inc. (Nasdaq:UTIW) today announced the signing of a contract with Wal-Mart Stores East, L.P. (an affiliate of Wal-Mart Stores, Inc.) (NYSE:WMT) awarding UTi's Standard Corporation the management of warehouse distribution services for a new import storage complex for Wal-Mart. The multi-million-square-foot Wal-Mart complex is scheduled to open in April 2005 and will be located in Baytown, Texas, 25 miles east of Houston near Galveston Bay.
Skandia Financial Effects 2004
STOCKHOLM, Sweden, Feb. 16, 2005 (PRIMEZONE) -- Skandia's result is affected by external factors such as changes in the stock market and interest rates. Future revenues, which are based on fund values, increase or decrease as a result of these factors.
Crucell and DSM Announce PER.C6(R) Licensing and Service Agreement with Roche for Protein Production
LEIDEN, The Netherlands, Feb. 16, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and allied contract manufacturer DSM Biologics announced today that they have signed a PER.C6(R) research license agreement with Roche. This license agreement allows Roche to use the PER.C6(R) cell line for production of monoclonal antibody products as well as a specific undisclosed protein.Roche has selected PER.C6(R) for this particular protein because it believes PER.C6(R) possesses unique features capable of delivering the appropriate product quality. Further to this agreement, Crucell will work with Roche in creating a production clone for the specific protein.
Crucell Receives Patents Covering PER.C6(R) for Protein Production
LEIDEN, The Netherlands, Feb. 16, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has been granted two pivotal patents relating to the production of proteins, one by the United States Patent and Trademark Office and the other by the European Patent Office. The U.S. Patent (No: 6,855,544) was granted on February 15, 2005, while the European patent (No: 1161548) was granted today.With these two patents Crucell considerably strengthens its patent position in and around the manufacturing of monoclonal antibodies and therapeutic proteins using cell lines and production technology marketed under its trademark PER.C6(R).
Skandia's Market Position in Sweden
STOCKHOLM, Sweden, Feb. 16, 2005 (PRIMEZONE) -- Tomorrow the Swedish Insurance Federation will be publishing the industry's quarterly statistics for the fourth quarter of 2004. These statistics also include information about Skandia's sales development. Consequently, in respect of the stock exchange listing agreement, Skandia is today releasing sales information for the fourth quarter of 2004.
Port of Houston Authority
PHA's Small Business Development Program Delivers Success
HOUSTON, Feb. 15, 2005 (PRIMEZONE) -- The Port of Houston Authority's Small Business Development Program (SBDP) achieved stellar performance results during 2004 through contract awards and purchase orders issued to hundreds of small business vendors. The SBDP is designed to help PHA contractors make good faith efforts to include small business participation in eligible contracts. The program's ultimate goal is to award at least 35 percent of all eligible contracts to small businesses. To date, in the three years since the inception of the PHA's small business program, a total of $76.2 million has been awarded or committed in contracts to eligible small businesses that have participated in the program.